Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1:223:108704.
doi: 10.1016/j.drugalcdep.2021.108704. Epub 2021 Apr 20.

Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis

Jean Y Ko  1 , Jangho Yoon  2 , Van T Tong  3 , Sarah C Haight  4 , Roshni Patel  5 , Karilynn M Rockhill  6 , Jeff Luck  2 , Carrie Shapiro-Mendoza  4
Affiliations

Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis

Jean Y Ko et al. Drug Alcohol Depend. .

Abstract

Background: We sought to describe healthcare utilization of infants by maternal opioid exposure and neonatal abstinence syndrome (NAS) status.

Methods: A longitudinal cohort of 81,833 maternal-infant dyads were identified from Oregon's 2008-2012 linked birth certificate and Medicaid eligibility and claims data. Chi-square tests compared term infants (≥37 weeks of gestational age) by maternal opioid exposure, defined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes or prescription fills, and NAS, defined using ICD-9-CM codes, such that infants were categorized as Opioid+/ NAS+, Opioid+/NAS-, Opioid-/NAS+, and Opioid-/NAS-. Modified Poisson regression was used to calculate adjusted risk ratios (aRR) and 95 % confidence intervals (CI) for healthcare utilization for each infant group compared to Opioid-/NAS- infants.

Results: The prevalence of documented maternal opioid exposure was 123.1 per 1000 dyads and NAS incidence was 5.8 per 1000 dyads. Compared to Opioid-/NAS- infants, infants with maternal opioid exposures were more likely to be hospitalized within 4 weeks (Opioid+/ NAS+: [aRR: 4.7; 95 % CI: 4.3-5.1]; Opioid+/ NAS-: [aRR: 3.7; 95 %CI: 3.1-4.5]) and a year after birth (Opioid+/ NAS+: [aRR: 3.7; 95 %CI: 3.4-4.0]; Opioid+/ NAS-: [aRR: 2.8; 95 %CI: 2.3-3.4]). Infants with maternal opioid exposure and/or NAS were more likely than Opioid-/NAS- infants to have ≥2 sick visits and any ED visits in the year after birth.

Conclusions: Infants with NAS and/or maternal opioid exposure had greater healthcare utilization than infants without NAS or opioid exposure. Efforts to mitigate future hospitalization risk and encourage participation in preventative services within the first year of life may improve outcomes.

Keywords: Healthcare; Infant; Medicaid; Neonatal abstinence syndrome; Opioids; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

No conflicts declared

Figures

Fig. 1.
Fig. 1.
Sample flow diagram of Medicaid financed hospital deliveries, Oregon, 2008–2012.
See this image and copyright information in PMC

References

    1. American College of Obstetricians and Gynecologists, 2017. Committee opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet. Gynecol 130, e81–94. 10.1097/AOG.0000000000002235. - DOI - PubMed
    1. Backes CH, Backes CR, Gardner D, Nankervis CA, Giannone PJ, Cordero L, 2012. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J. Perinatol 32, 425–430. 10.1038/jp.2011.114. - DOI - PMC - PubMed
    1. Chi DL, Momany ET, Jones MP, Kuthy RA, Askelson NM, Wehby GL, Damiano PC, 2013. An explanatory model of factors related to well baby visits by age three years for Medicaid-enrolled infants: a retrospective cohort study. BMC Pediatr. 13, 158. 10.1186/1471-2431-13-158. - DOI - PMC - PubMed
    1. Chiang KV, Okoroh EM, Kasehagen LJ, Garcia-Saavedra LF, Ko JY, 2019. Standardization of state definitions for neonatal abstinence syndrome surveillance and the opioid crisis. Am. J. Public Health 109, 1193–1197. 10.2105/AJPH.2019.305170. - DOI - PMC - PubMed
    1. Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT, 2015. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 350, h2102. 10.1136/bmj.h2102. - DOI - PMC - PubMed

Publication types

Substances